← All trials
NCT05174169
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 10, 2022
- Primary completion
- Mar 10, 2029
- Completion date
- Mar 10, 2030
- First posted
- Dec 30, 2021
- Last posted
- Mar 31, 2022
- Enrollment
- 1912
- Arms / groups
- 4 / —
- Source
- AACT · ctgov ingestion
Sponsors
- NRG OncologyLead sponsor
- National Cancer Institute (NCI)Collaborator
- Natera, Inc.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.